Table 4 Survival analysis of patients depending on M30 status of DTC
Patients with primary surgery | Patients with NST | |
|---|---|---|
N | 298 | 85 |
Deaths | 21 | 7 |
M30 positive | 10/82 (12%) | 4/41 (10%) |
M30 negative | 11/216 (5%) | 3/44 (7%) |
P | 0.032 | n.s. |
Overall survival* | ||
(M30 positive vs M30 negative) | 0.008 | n.s. |
Relapses† | 19 | 13 |
M30 positive | 7/82 (9%) | 3/41 (7%) |
M30 negative | 12/216 (6%) | 10/44 (23%) |
P | n.s. | 0.049 |
Relapse free survival* | n.s. | 0.128 |
(M30 positive vs M30 negative) |